Exploring the therapeutic potential of leaf extract against amyloid-beta-induced toxicity in the model of Alzheimer's disease.

Alzheimer's disease (AD) represents a critical global health challenge with limited therapeutic options, prompting the exploration of alternative strategies. A key pathology in AD involves amyloid beta (Aβ) aggregation, and targeting both Aβ aggregation and oxidative stress is crucial for effective intervention. Natural compounds from medicinal and food sources have emerged as potential preventive and therapeutic agents, with leaf extract (NLE) showing promising properties.